Myeloid sarcoma (MS) is an invasive extramedullary solid tumor composed of immature
cells of the myeloid series. It complicates the clinical course of a minority of patients with …

Myeloid sarcoma (MS) is a neoplastic growth of myeloblasts or immature myeloid cells
arising in an extra-medullary site or in the bone. MS may precede, occur simultaneously or …

Myeloid sarcomas are extramedullary tumours with granulocytic precursors. When
associated with acute myelogenous leukaemia (AML), these tumours usually affect no more …

Myeloid sarcoma is an extramedullary manifestation of Acute Myeloid Leukaemia and
sometimes is the only indicator of the disease. The incidence varies between 3-9.1% of …

Myeloid sarcoma (MS) is defined as a tumor mass consisting of myeloid blast with or without
maturation occurring at an anatomical site other than bone marrow with normal architectural …

Myeloid sarcoma (MS) in the setting of concomitant medullary AML is relatively well
described, while much less is known about patients presenting with MS with< 20% bone …

In a general surgical pathology practice, cases of acute myeloid leukemia (AML), including
myeloid sarcoma, are relatively rare; the diagnosis is very often difficult, however, and …

Myeloid sarcoma (MS) are extramedullary tumor masses consisting of a proliferation of
myeloid immature cells that efface the underlying tissue architecture.[1] It may develop de …

Myeloid sarcoma (MS) is a rare neoplastic condition that is often described in association
with acute myeloid leukemia (AML). MS in childhood has received little attention, particularly …

BACKGROUND. It is unknown whether patients with nonleukemic myeloid sarcoma (MS)
and those with acute myeloid leukemia (AML) have similar responses to anti‐AML treatment …